Cardioprotective Drug Prevents Severe Cardiac Events in Children Undergoing Chemotherapy for Acute Myeloid Leukemia

The cardioprotective drug dexrazoxane preserved cardiac function in pediatric patients undergoing chemotherapy for acute myeloid leukemia (AML) without compromising overall patient survival and potentially improving it, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP). The results suggest dexrazoxane should be considered for cardioprotection in all pediatric patients undergoing standard chemotherapy for AML.

Read more

Study sheds light on fatty acid’s role in “chemobrain” and multiple sclerosis

A study led by The University of Texas MD Anderson Cancer Center has found that myelin is surprisingly dynamic, a discovery that has implications for treatment of multiple sclerosis and a type of myelin damage caused by some chemotherapy drugs, often referred to as “chemobrain.”

Read more

Baylor University Interior Design Team Helps Prepare a Hyperclean Play Space for Children with Compromised Immunity

A Baylor University interior design team is assisting Decon7 Systems — manufacturer of a powerful disinfectant used by the military, first responders and, most recently, hospitals in China as they battle Coronavirus Disease (COVID-19) 19 — in designing a hyperclean play space for children with diseases that compromise their immunity.

Read more

Exercise during Chemo, Activity Breaks Enhance Mood, Reducing Diabetes Risk in African American Men & More from Medicine & Science in Sports & Science

If you’re looking for health and fitness story ideas, view these research highlights from Exercise and Sport Sciences Reviews and Medicine & Science in Sports & Exercise®, ACSM’s flagship research journal.

Read more